Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Clinical and Diagnostic Laboratory Immunology|January 5, 2002
Standardization of Neisseria meningitidis serogroup B colorimetric serum bactericidal assayTamara Rodríguez, Miriam Lastre, Barbara Cedré, et al.
Methods (San Diego, Calif.)|May 5, 2009
Mucosal immunization using proteoliposome and cochleate structures from Neisseria meningitidis serogroup B induce mucosal and systemic responsesJudith Del Campo, Caridad Zayas, Belkis Romeu, et al.
Vaccine|July 11, 2006
Immunological evaluation of bacterial derived Cochleate and proteoliposome as mucosal adjuvantsJudith del Campo, Miriam Lastre, Gustavo Bracho, et al.
Vaccine|July 11, 2006
Adjuvant properties of lipopolysaccharide from Neisseria meningitidis serogroup B detoxified and conjugated with tetanus toxoidJulio A Balboa, Maribel Cuello, Osmir Cabrera, et al.
Scandinavian Journal of Infectious Diseases|June 16, 2011
AFCo1 as nasal adjuvant of capsular polysaccharide from Neisseria meningitidis serogroup C induces systemic and mucosal immune responsesBelkis Romeu, Elizabeth González, Caridad Zayas, et al.
Canadian Journal of Microbiology|March 2, 2011
Mucosal and systemic immune responses of mice to tetanus toxoid coadministered nasally with AFCo1Belkis Romeu, Elyzabeth González, Judith Del Campo, et al.
Vaccine|July 11, 2006
Scale up of proteoliposome derived Cochleate productionCaridad Zayas, Gustavo Bracho, Miriam Lastre, et al.
Frontiers in Immunology|December 19, 2013
Adjuvants are Key Factors for the Development of Future Vaccines: Lessons from the Finlay Adjuvant PlatformOliver Pérez, Belkis Romeu, Osmir Cabrera, et al.
Vaccine|July 11, 2006
Bacterial derived proteoliposome for allergy vaccinesMiriam Lastre, Oliver Pérez, Alexis Labrada, et al.
BMC Immunology|March 6, 2013
Pilot scale production of the vaccine adjuvant Proteoliposome derived Cochleates (AFCo1) from Neisseria meningitidis serogroup BCaridad Zayas, Domingo González, Reinaldo Acevedo, et al.
Pageof 3